These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9415267)

  • 1. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes.
    Lee JA; Allen DG
    Cardiovasc Res; 1997 Oct; 36(1):10-20. PubMed ID: 9415267
    [No Abstract]   [Full Text] [Related]  

  • 2. [If the myofilaments become sensitive: Ca2+-sensitizer for the therapy of heart insufficiency].
    Schwinger RH; Brixius K
    Dtsch Med Wochenschr; 2005 Apr; 130(15):969-73. PubMed ID: 15812725
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium sensitization as a positive inotropic mechanism in diseased rat and human heart.
    Nankervis R; Lues I; Brown L
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):612-7. PubMed ID: 7528844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
    Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M
    J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of inotropic agents in acute and chronic congestive heart failure.
    Sanders MR; Kostis JB; Frishman WH
    Med Clin North Am; 1989 Mar; 73(2):283-314. PubMed ID: 2645478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New positive inotropic agents.
    Jafri SM; Bristol JA
    Henry Ford Hosp Med J; 1986; 34(3):188-92. PubMed ID: 3542907
    [No Abstract]   [Full Text] [Related]  

  • 8. New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
    Holubarsch C
    Cardiology; 1997; 88 Suppl 2():12-20. PubMed ID: 9142431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 10. Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.
    Tauke J; Han D; Gheorghiade M
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):761-8. PubMed ID: 7873474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of novel cardiotonic agents.
    Endoh M
    Expert Opin Investig Drugs; 2003 May; 12(5):735-50. PubMed ID: 12720486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phosphodiesterase inhibition as a new positive-inotropic principle].
    Hartmann A; Saeed M; Sütsch G; Bing RJ
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1971-7. PubMed ID: 3539571
    [No Abstract]   [Full Text] [Related]  

  • 13. The search for the ideal positive inotropic agent.
    Packer M
    N Engl J Med; 1993 Jul; 329(3):201-2. PubMed ID: 8515793
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive inotropic agents in congestive heart failure.
    Homoud MK; Chuttani K; Konstam MA
    Coron Artery Dis; 1993 Jan; 4(1):44-52. PubMed ID: 7903591
    [No Abstract]   [Full Text] [Related]  

  • 15. Inotropic agents and immune modulation.
    Sasayama S
    Cardiovasc Drugs Ther; 2002 May; 16(3):237-43. PubMed ID: 12374902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 17. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
    Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 20. Another calcium paradox in heart failure.
    Kass RS; Lindegger N; Hagen B; Lederer WJ
    J Mol Cell Cardiol; 2008 Jul; 45(1):28-31. PubMed ID: 18504047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.